These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29019059)

  • 1. Systematical Investigation of Different Drug Nanocrystal Technologies to Produce Fast Dissolving Meloxicam Tablets.
    Liu T; Yao G; Zhang X; Zuo X; Wang L; Yin H; Möschwitzer JP
    AAPS PharmSciTech; 2018 Feb; 19(2):783-791. PubMed ID: 29019059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.
    Iurian S; Bogdan C; Tomuță I; Szabó-Révész P; Chvatal A; Leucuța SE; Moldovan M; Ambrus R
    Eur J Pharm Sci; 2017 Jun; 104():356-365. PubMed ID: 28435075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
    Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
    Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Top-down and Bottom-up Approaches by Using Design of Experiment (DoE) to Produce Meloxicam Nanocrystal Capsules.
    Liu T; Yu X; Yin H
    AAPS PharmSciTech; 2020 Jan; 21(3):79. PubMed ID: 31974817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of drug nanosuspensions: effect of drug physical properties on nanosizing efficiency.
    Liu T; Müller RH; Möschwitzer JP
    Drug Dev Ind Pharm; 2018 Feb; 44(2):233-242. PubMed ID: 28956456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance comparison of two novel combinative particle-size-reduction technologies.
    Salazar J; Müller RH; Möschwitzer JP
    J Pharm Sci; 2013 May; 102(5):1636-49. PubMed ID: 23436640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active freeze drying for production of nanocrystal-based powder: A pilot study.
    Touzet A; Pfefferlé F; der Wel PV; Lamprecht A; Pellequer Y
    Int J Pharm; 2018 Jan; 536(1):222-230. PubMed ID: 29175644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel high-pressure precipitation tandem homogenization technology for drug nanocrystals production - a case study with ursodeoxycholic acid.
    Li Y; Wang Y; Yue PF; Hu PY; Wu ZF; Yang M; Yuan HL
    Pharm Dev Technol; 2014 Sep; 19(6):662-70. PubMed ID: 23869484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.
    Salazar J; Ghanem A; Müller RH; Möschwitzer JP
    Eur J Pharm Biopharm; 2012 May; 81(1):82-90. PubMed ID: 22233547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation Nanocrystals of Poorly Soluble Plant Compounds Using an Ultra-Small-Scale Approach.
    Liu T; Yao G; Liu X; Yin H
    AAPS PharmSciTech; 2017 Oct; 18(7):2610-2617. PubMed ID: 28243886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications.
    Tuomela A; Laaksonen T; Laru J; Antikainen O; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2015 May; 485(1-2):77-86. PubMed ID: 25746735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematical investigation of a combinative particle size reduction technology for production of resveratrol nanosuspensions.
    Liu T; Müller RH; Möschwitzer JP
    AAPS PharmSciTech; 2017 Jul; 18(5):1683-1691. PubMed ID: 27696301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New method for the effective production of ultrafine drug nanocrystals.
    Möschwitzer J; Müller RH
    J Nanosci Nanotechnol; 2006; 6(9-10):3145-53. PubMed ID: 17048530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Drug Brittleness, Nanomilling Time, and Freeze-Drying on the Crystallinity of Poorly Water-Soluble Drugs and Its Implications for Solubility Enhancement.
    Colombo M; Orthmann S; Bellini M; Staufenbiel S; Bodmeier R
    AAPS PharmSciTech; 2017 Oct; 18(7):2437-2445. PubMed ID: 28168626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam.
    Bartos C; Szabó-Révész P; Bartos C; Katona G; Jójárt-Laczkovich O; Ambrus R
    Molecules; 2016 Apr; 21(4):507. PubMed ID: 27110752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stability testing of meloxicam-containing microcomposites for inhalation].
    Pomázi A; Ambrus R; Szabóné Révész P
    Acta Pharm Hung; 2014; 84(2):55-62. PubMed ID: 25167700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
    Xu D; Ni R; Sun W; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Apr; 41(4):552-9. PubMed ID: 24495272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.